BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

TCI Biotech Elevates CDMO+ Services with US-Based Glass Bottling for Liquid Supplements

TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling s...

April 03, 2025 | News

SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...

April 02, 2025 | News

Langhua Pharmaceutical Receives FDA EIR Following Successful cGMP Inspection for the Fourth Time

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP...

March 31, 2025 | News

Thermo Fisher Introduces Vulcan™ Automated Lab to Advance Semiconductor Process Development

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the launch of the Thermo...

March 19, 2025 | News

WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...

March 04, 2025 | News

Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...

February 24, 2025 | News

LG Chem Begins Prototype Production of 100% Bio-Acrylic Acid in South Korea

LG Chem has launched prototype production of 100% bio-acrylic acid, which has received USDA Certified Biobased Product (BIOPREFERRED®) label. The pr...

February 13, 2025 | News

Wellumio’s Portable MRI ‘Axana’ Begins First Clinical Study in Australia for Rapid Stroke Detection

Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patien...

February 07, 2025 | News

Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production

3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor...

February 05, 2025 | News

Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies

Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...

January 16, 2025 | News

ADELA Phase III Trial Combines Elacestrant and Everolimus to Tackle Advanced ER+/HER2- Breast Cancer with ESR1 Mutations

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breas...

December 13, 2024 | News

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

Hong Kong’s Viva Biotech Expands Global Footprint with Strategic Boston Branch Launch

Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug re...

December 12, 2024 | News

Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology

In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...

November 01, 2024 | Interview

Stay Connected